Cargando…

Potential use of glutathione as a treatment for Parkinson's disease

The aim of the present study was to assess the efficacy and safety of glutathione (GSH) for the treatment of Parkinson's disease (PD). The PubMed, Cochrane Library, OvidSP, Web of Science, China Science and Technology Journal Database, Chinese National Knowledge Infrastructure and China Wanfang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hai-Li, Zhang, Jun, Li, Yu-Ping, Dong, Lun, Chen, Ying-Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751460/ https://www.ncbi.nlm.nih.gov/pubmed/33376507 http://dx.doi.org/10.3892/etm.2020.9557

Ejemplares similares

Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson's Disease
por: Li, Xiang-Yun, et al.
Publicado: (2015)

Polymorphisms of Cytochromes P450 and Glutathione S-Transferases Synergistically Modulate Risk for Parkinson’s Disease
por: Fan, Hui-Hui, et al.
Publicado: (2022)

Glutathione and Related Molecules in Parkinsonism
por: Asanuma, Masato, et al.
Publicado: (2021)

Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease
por: Mischley, Laurie K., et al.
Publicado: (2017)

Effect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease
por: Wang, Fang, et al.
Publicado: (2015)

Central nervous system uptake of intranasal glutathione in Parkinson’s disease
por: Mischley, Laurie K, et al.
Publicado: (2016)

Glutathione as a Biomarker in Parkinson's Disease: Associations with Aging and Disease Severity
por: Mischley, Laurie K., et al.
Publicado: (2016)

Freezing of Gait in Parkinsonism and its Potential Drug Treatment
por: Zhang, Li-Li, et al.
Publicado: (2016)

The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's Disease
por: Li, Xiaoliang, et al.
Publicado: (2017)

Targeting the Cysteine Redox Proteome in Parkinson’s Disease: The Role of Glutathione Precursors and Beyond
por: Martinez-Banaclocha, Marcos A.
Publicado: (2023)

A meta-analysis of association between glutathione S-transferase M1 gene polymorphism and Parkinson’s disease susceptibility
por: Weikang, Chen, et al.
Publicado: (2016)

Current approaches for the management of Parkinson’s disease in Chinese hospitals: a cross-sectional survey
por: Wang, Gang, et al.
Publicado: (2018)

Glutathione S-transferase π: a potential role in antitumor therapy
por: Dong, Shu-Chen, et al.
Publicado: (2018)

Identification of Parkinson’s disease-related pathways and potential risk factors
por: Shen, Jun, et al.
Publicado: (2020)

Factors Contributing to Malnutrition in Parkinson's Disease Patients With Freezing of Gait
por: Zhang, Li-Li, et al.
Publicado: (2022)

Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson’s Disease
por: Zhu, Sha, et al.
Publicado: (2022)

Can Quantitative Gait Analysis Be Used to Guide Treatment of Patients with Different Subtypes of Parkinson’s Disease?
por: Wu, Zhuang, et al.
Publicado: (2020)

Benefits of Vitamins in the Treatment of Parkinson's Disease
por: Zhao, Xiuzhen, et al.
Publicado: (2019)

Reduced glutathione and glutathione disulfide in the blood of glucose-6-phosphate dehydrogenase-deficient newborns
por: Gong, Zhen-hua, et al.
Publicado: (2017)

Effects of different drugs and hormone treatment on Toxoplasma gondii glutathione S-transferase 2
por: Li, Shuang, et al.
Publicado: (2022)

The efficacy of homemade tolcapone in the treatment of patients with Parkinsons disease
por: Zhang, Pei-Lan, et al.
Publicado: (2018)

Identification of Potential Core Genes in Parkinson's Disease Using Bioinformatics Analysis
por: Quan, Wei, et al.
Publicado: (2021)

Tonic Electromyogram Density in Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease
por: Wang, Yi, et al.
Publicado: (2017)

Hepatic glutathione and glutathione S-conjugate transport mechanisms.
por: Lee, T. K., et al.
Publicado: (1997)

Systematic manipulation of glutathione metabolism in Escherichia coli for improved glutathione production
por: Zhang, Jing, et al.
Publicado: (2016)

Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease
por: Yan, Fudong, et al.
Publicado: (2018)

Deep Brain Stimulation: A Potential Treatment for Dementia in Alzheimer's Disease (AD) and Parkinson's Disease Dementia (PDD)
por: Lv, Qing, et al.
Publicado: (2018)

Glutathione Levels and Glutathione-Glutamate Correlation in Patients With Treatment-Resistant Schizophrenia
por: Iwata, Yusuke, et al.
Publicado: (2021)

Mild Gait Impairment and Its Potential Diagnostic Value in Patients with Early-Stage Parkinson's Disease
por: Wu, Zhuang, et al.
Publicado: (2021)

Noncanonical Roles of hα-syn (A53T) in the Pathogenesis of Parkinson's Disease: Synaptic Pathology and Neuronal Aging
por: Wang, Qing-Jun, et al.
Publicado: (2020)

Potential Role of Caffeine in the Treatment of Parkinson’s Disease
por: Roshan, Mohsin H.K., et al.
Publicado: (2016)

Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
por: Królicka, Ewelina, et al.
Publicado: (2022)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Musculoskeletal Pain in Parkinson's Disease
por: Li, Jun, et al.
Publicado: (2022)

Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease
por: Zhang, Kai, et al.
Publicado: (2021)

Glutathione S-Transferase Omega 1 Activity Is Sufficient to Suppress Neurodegeneration in a Drosophila Model of Parkinson Disease
por: Kim, Kiyoung, et al.
Publicado: (2012)

The Potential Role of Voltage-Dependent Anion Channel in the Treatment of Parkinson's Disease
por: He, Yajie, et al.
Publicado: (2022)

Spectrofluorimetric assay method for glutathione and glutathione transferase using monobromobimane
por: Yakubu, S. I., et al.
Publicado: (2011)

The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment
por: Heris, Reza Mosaddeghi, et al.
Publicado: (2022)

A Preliminary Study on the Potential Protective Role of the Antioxidative Stress Markers of Cognitive Impairment: Glutathione and Glutathione Reductase
por: Park, Sang-a, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0hks9dhst5rop8jqdf12tefu2